Strategies and Solutions to Salvage the Credibility of the Pharmaceutical Industry

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/3af5f7/keywordpharma_conf)
has announced the addition of the "KeywordPharma Conference Insights -
Strategies and Solutions for Publication Planning and Execution
Excellence" report to their offering.

The world of medical publishing is complicated and fast-moving. It
involves complex relationships between journal editors, academic
investigators and publication professionals working in or for
pharmaceutical companies. The 5th Annual Meeting of The International
Publication Planning Association (TIPPA) highlighted the need for
companies to keep abreast of the latest rules and regulations and to
develop guidelines and policies to improve the publication planning
process. Such improvements may, in turn, help repair the image of the
sector, and restore public trust in industry-sponsored publications
which has been damaged recently.

A wide range of issues was addressed. Transparency, disclosure and
compliance emerged as keywords. The need to develop and maintain
robust company policies that reflect changing publications
requirements was also noted. In addition, the meeting looked at
authorship guidelines, the latest developments in results disclosure,
and the impact of cost-cutting and globalisation on publication
planning.

The publication planning process requires cooperation from a
diverse group of people and input from a number of different sources.
Coordinating such teams and drawing together such information to
create transparent, unbiased and educational documents for publication
is a major challenge. Likewise, creating, maintaining and enforcing
effective company policies can be challenging.

The 5th TIPPA meeting provided a valuable information exchange for
stakeholders across the industry, offering practical guidance for all
those seeking publication planning and execution excellence.

Executive Summary:

The reputation of the global pharmaceutical industry is currently
suffering, and there is public mistrust of drug companies' publication
practices. The industry can only eradicate this problem through
increased transparency, honesty and openness in its publications.
Clearly, the provision of unbiased information to medical decision
makers is essential, not only for the sake of the industry's image,
but, more importantly, for the good of public health.

In an environment of rapidly changing rules and regulations,
pharmaceutical companies must develop their own robust publication
policies that reflect the latest guidelines. Crucially, they must also
develop compliance programmes to ensure that all those working on
publications not only understand company policy, but actively
implement it.

This Conference Insights review provides an in-depth review of the
5th Annual Meeting of The International Publication Planning
Association held in San Francisco, CA, 25-26 June 2007. It details the
major challenges facing publications professionals, including the need
for disclosure, transparency and compliance. It offers guidance on how
to develop and implement company policy, looks at the involvement of
marketing in the publication process, the growth of open-access
publishing and how agencies and drug companies can develop effective
partnerships.

-0-
*T
Key Topics Covered:

Key Topics

-Legal issues
-An editor's perspective
-The role of marketing in developing publications
-Payments for authors
-Developing a company publication policy
-Leading publication teams
-Problems with authorship
-Effects of cost-cutting and global sourcing
-The latest on open-access publishing
-Developments in results disclosure
-Conclusions
-References
*T

For more information visit
http://www.researchandmarkets.com/research/3af5f7/keywordpharma_conf

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax (USA): 646-607-1907
Fax (International): +353-1-481-1716

Copyright Business Wire 2008